These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27041577)

  • 1. CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor.
    Nodomi S; Umeda K; Saida S; Kinehara T; Hamabata T; Daifu T; Kato I; Hiramatsu H; Watanabe KI; Kuwahara Y; Iehara T; Adachi S; Konishi E; Nakahata T; Hosoi H; Heike T
    Oncogene; 2016 Oct; 35(40):5317-5327. PubMed ID: 27041577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD146 is a potential immunotarget for neuroblastoma.
    Obu S; Umeda K; Ueno H; Sonoda M; Tasaka K; Ogata H; Kouzuki K; Nodomi S; Saida S; Kato I; Hiramatsu H; Okamoto T; Ogawa E; Okajima H; Morita K; Kamikubo Y; Kawaguchi K; Watanabe K; Iwafuchi H; Yagyu S; Iehara T; Hosoi H; Nakahata T; Adachi S; Uemoto S; Heike T; Takita J
    Cancer Sci; 2021 Nov; 112(11):4617-4626. PubMed ID: 34464480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Two MRT Cell Lines Established from Multiple Sites of a Synchronous MRT Patient.
    Kuwahara Y; Iehara T; Ichise E; Katsumi Y; Ouchi K; Tsuchiya K; Miyachi M; Konishi E; Sasajima H; Nakamura S; Fumino S; Tajiri T; Johann PD; FrÜhwald MC; Yoshida T; Okuda T; Hosoi H
    Anticancer Res; 2020 Nov; 40(11):6159-6170. PubMed ID: 33109553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours.
    Custers L; Khabirova E; Coorens THH; Oliver TRW; Calandrini C; Young MD; Vieira Braga FA; Ellis P; Mamanova L; Segers H; Maat A; Kool M; Hoving EW; van den Heuvel-Eibrink MM; Nicholson J; Straathof K; Hook L; de Krijger RR; Trayers C; Allinson K; Behjati S; Drost J
    Nat Commun; 2021 Mar; 12(1):1407. PubMed ID: 33658498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of gefitinib in malignant rhabdoid tumor cells in vitro and in vivo.
    Kuwahara Y; Hosoi H; Osone S; Kita M; Iehara T; Kuroda H; Sugimoto T
    Clin Cancer Res; 2004 Sep; 10(17):5940-8. PubMed ID: 15355927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a pineal region malignant rhabdoid tumor. Towards understanding brain tumor cell invasion.
    Muller M; Hubbard SL; Fukuyama K; Dirks P; Matsuzawa K; Rutka JT
    Pediatr Neurosurg; 1995; 22(4):204-9. PubMed ID: 7619721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CD146 as a marker enriched for tumor-propagating capacity reveals targetable pathways in primary human sarcoma.
    Wei Q; Tang YJ; Voisin V; Sato S; Hirata M; Whetstone H; Han I; Ailles L; Bader GD; Wunder J; Alman BA
    Oncotarget; 2015 Nov; 6(37):40283-94. PubMed ID: 26517673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies of the origin of malignant rhabdoid tumor(MRT)--experimental researches on the MRT evolving in nude mice inoculated with violently variable HeLa cells].
    Zhang DL; Huang GS; Li LJ; He XY; Xia GT; Gao BX; Bai XH; Liu SG
    Yi Chuan Xue Bao; 2000; 27(12):1057-71. PubMed ID: 11209698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.
    Oda Y; Tsuneyoshi M
    Pathol Int; 2006 Jun; 56(6):287-95. PubMed ID: 16704491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress.
    Li T; Wang J; Liu P; Chi J; Yan H; Lei L; Li Z; Yang B; Wang X
    Oncotarget; 2017 Jul; 8(29):47269-47283. PubMed ID: 28521298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant rhabdoid tumor shows incomplete neural characteristics as revealed by expression of SNARE complex.
    Yoshida S; Narita T; Taga T; Ohta S; Takeuchi Y
    J Neurosci Res; 2002 Sep; 69(5):642-52. PubMed ID: 12210830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example.
    Golan H; Shukrun R; Caspi R; Vax E; Pode-Shakked N; Goldberg S; Pleniceanu O; Bar-Lev DD; Mark-Danieli M; Pri-Chen S; Jacob-Hirsch J; Kanter I; Trink A; Schiby G; Bilik R; Kalisky T; Harari-Steinberg O; Toren A; Dekel B
    Stem Cell Reports; 2018 Sep; 11(3):795-810. PubMed ID: 30122444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of malignant rhabdoid tumors through Chb-M'-mediated RUNX1 inhibition.
    Daifu T; Mikami M; Hiramatsu H; Iwai A; Umeda K; Noura M; Kubota H; Masuda T; Furuichi K; Takasaki S; Noguchi Y; Morita K; Bando T; Hirata M; Kataoka TR; Nakahata T; Kuwahara Y; Iehara T; Hosoi H; Takita J; Sugiyama H; Adachi S; Kamikubo Y
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28789. PubMed ID: 33180377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumor.
    Armeanu-Ebinger S; Herrmann D; Bonin M; Leuschner I; Warmann SW; Fuchs J; Seitz G
    Exp Cell Res; 2012 Dec; 318(20):2567-77. PubMed ID: 23000453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INI1 expression induces cell cycle arrest and markers of senescence in malignant rhabdoid tumor cells.
    Reincke BS; Rosson GB; Oswald BW; Wright CF
    J Cell Physiol; 2003 Mar; 194(3):303-13. PubMed ID: 12548550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of neural stem cell markers in malignant rhabdoid tumor cell lines.
    Okuno K; Ohta S; Kato H; Taga T; Sugita K; Takeuchi Y
    Oncol Rep; 2010 Feb; 23(2):485-92. PubMed ID: 20043111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric extra-renal rhabdoid tumors with unusual morphology: a diagnostic pitfall for small biopsies.
    Alaggio R; Boldrini R; Di Venosa B; Rosolen A; Bisogno G; Magro G
    Pathol Res Pract; 2009; 205(7):451-7. PubMed ID: 19243895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
    Darr J; Klochendler A; Isaac S; Eden A
    Oncogene; 2014 Jun; 33(23):3024-32. PubMed ID: 23851500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant rhabdoid-tumor cell line showing neural and smooth-muscle-cell phenotypes.
    Sugimoto T; Hosoi H; Horii Y; Ishida H; Mine H; Takahashi K; Abe T; Ohta S; Sawada T
    Int J Cancer; 1999 Aug; 82(5):678-86. PubMed ID: 10417765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional screening of the kinome identifies the Polo-like kinase 4 as a potential therapeutic target for malignant rhabdoid tumors, and possibly, other embryonal tumors of the brain.
    Sredni ST; Suzuki M; Yang JP; Topczewski J; Bailey AW; Gokirmak T; Gross JN; de Andrade A; Kondo A; Piper DR; Tomita T
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28398638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.